Patents by Inventor Filippos Touriomousis

Filippos Touriomousis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and apparatus for variable emulsification
    Patent number: 11666874
    Abstract: The invention comprises a novel modular, generalizable meso-micro-nano-fluidic platform apparatus, design and methodology which in exemplary embodiments may be applied in conjunction with a novel external triggering and automation/feedback loop control mechanism deployed via computer to explore the phase space of single or double emulsification for applications including the encapsulation of hydrophilic active pharmacological ingredients (APIs). End use applications include the mass production of particulate encapsulation of hydrophobic or hydrophilic APIs with automatic or user-supervised feedback methodology to control and discover mass production or per-drug customized settings of interest for the manufacture of novel or extant therapeutics.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: June 6, 2023
    Assignees: Glaxosmithkline Intellectual Property Deveelopment Limited, Massachusetts Institute of Technology
    Inventors: David Lai, Filippos Touriomousis, Andreas Mershin, Neil Gershenfeld
  • METHODS AND APPARATUS FOR VARIABLE EMULSIFICATION
    Publication number: 20190184351
    Abstract: The invention comprises a novel modular, generalizable meso-micro-nano-fluidic platform apparatus, design and methodology which in exemplary embodiments may be applied in conjunction with a novel external triggering and automation/feedback loop control mechanism deployed via computer to explore the phase space of single or double emulsification for applications including the encapsulation of hydrophilic active pharmacological ingredients (APIs). End use applications include the mass production of particulate encapsulation of hydrophobic or hydrophilic APIs with automatic or user-supervised feedback methodology to control and discover mass production or per-drug customized settings of interest for the manufacture of novel or extant therapeutics.
    Type: Application
    Filed: August 2, 2018
    Publication date: June 20, 2019
    Applicant: Massachusetts Institute of Technology
    Inventors: David Lai, Filippos Touriomousis, Andreas Mershin, Neil Gershenfeld